MEDINET CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45 JPY | 0.00% |
|
0.00% | +4.65% |
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
Calendar
2024-05-09
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +4.65% | 73.24M | |
| +2.43% | 42.75B | |
| +47.70% | 41.61B | |
| +12.06% | 41.34B | |
| -8.83% | 26.59B | |
| +6.65% | 25.49B | |
| -22.87% | 18.12B | |
| +30.41% | 12.24B | |
| -2.05% | 11.76B | |
| +9.21% | 11B |
- Stock Market
- Equities
- 2370 Stock
- Funds and ETFs MEDINET Co., Ltd.
